Catherine H. Van Poznak, Joseph M. Unger u. a.: Association of Osteonecrosis of the Jaw With Zoledronic Acid Treatment for Bone Metastases in Patients With Cancer. In: JAMA Oncology. , doi:10.1001/jamaoncol.2020.6353.
Black et al. Once-Yearly Zoledronic Acid for Treatment of Postmenopausal Osteoporosis. NEJM 2007;356;18;1809-1822. AbstractPMID 17476007.
Lyles KW et al.: Zoledronic acid and clinical fractures and mortality after hip fracture. N Engl J Med. 2007 Nov 1;357(18):1799-809. Epub 2007 Sep 17. Volltext (HTML)Volltext (PDF), PMID 17878149.
nih.gov
ncbi.nlm.nih.gov
Black et al. Once-Yearly Zoledronic Acid for Treatment of Postmenopausal Osteoporosis. NEJM 2007;356;18;1809-1822. AbstractPMID 17476007.
Lyles KW et al.: Zoledronic acid and clinical fractures and mortality after hip fracture. N Engl J Med. 2007 Nov 1;357(18):1799-809. Epub 2007 Sep 17. Volltext (HTML)Volltext (PDF), PMID 17878149.